- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
VEEV
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Veeva Systems Inc. · Healthcare · Health Information Services
Latest close
199.4 EUR
14.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 28.2% above the Trend Line and sits at 52.3% of its 52-week range. The latest completed week returned 14.1%, after a 19.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
36
out of 100
Latest Close
199.4 EUR
7 Aug 2026
1W Return
14.1%
latest completed week
4W Return
19.7%
short-term follow-through
12W Return
46.8%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
-
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
14.1%
Latest completed week; four-week move 19.7%.
Indicator stack
15/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
26 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 28.2% above the Trend Line and sits at 52.3% of its 52-week range. The latest completed week returned 14.1%, after a 19.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1712-week average 0.08
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 19.7% over four weeks, 46.8% over 12 weeks, and -16.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.08Latest activity-pressure read.
Pressure change33.0%Four-week change in activity pressure.
Leadership-14.74Latest relative-leadership reading.
RS change52.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 26 relevant articles.
2 positive · 22 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.6%Distance below the 52-week high.
13-week volatility6.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+14.1%Week of 7 Aug.
Worst week-14.8%Week of 10 Apr.
Latest week+14.1%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains4
Flat weeks0
Modest losses7
Sharp losses6
Recent vol6.9%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank3 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Health Information Services
4-week rank1 / 1
Group average19.7%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis31/100Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.17; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 26 relevant articles.
BlackRock, Inc. Adds to Veeva Systems Inc (VEEV) Stake -- Shares Look 27% Undervalued on GF Value Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 199.4 EUR | 14.1% | 155.5 EUR | 194.9 EUR | 1.08 | -14.74 | 0 | Off |
| 31 Jul 2026 | 174.6 EUR | 6.7% | 155.8 EUR | 194.8 EUR | 1.10 | -23.92 | 0 | Off |
| 24 Jul 2026 | 163.6 EUR | -4.1% | 156.2 EUR | 194.8 EUR | 1.11 | -29.73 | 0 | Off |
| 17 Jul 2026 | 170.6 EUR | 2.5% | 157.1 EUR | 194.9 EUR | 1.06 | -26.80 | 0 | Off |
| 10 Jul 2026 | 166.5 EUR | -0.9% | 157.7 EUR | 194.9 EUR | 0.81 | -30.88 | 39 | Off |
| 3 Jul 2026 | 168.1 EUR | 13.4% | 158.5 EUR | 195.1 EUR | 0.51 | -32.02 | 0 | Off |
| 26 Jun 2026 | 148.2 EUR | 10.7% | 159.9 EUR | 195.1 EUR | 0.51 | -39.43 | 0 | Off |
| 19 Jun 2026 | 133.9 EUR | -2.3% | 161.9 EUR | 195.3 EUR | 0.45 | -47.14 | 0 | Off |
| 12 Jun 2026 | 137.1 EUR | -8.6% | 164.4 EUR | 195.7 EUR | 0.51 | -44.55 | 0 | Off |
| 5 Jun 2026 | 150.1 EUR | 0.3% | 168.2 EUR | 196.0 EUR | 0.59 | -38.60 | 217 | Off |
| 29 May 2026 | 149.6 EUR | 8.6% | 171.6 EUR | 196.1 EUR | 0.28 | -40.35 | 0 | Off |
| 22 May 2026 | 137.7 EUR | 1.4% | 175.0 EUR | 196.4 EUR | -0.04 | -44.37 | 39 | Off |
| 15 May 2026 | 135.8 EUR | -3.2% | 178.8 EUR | 196.5 EUR | -0.30 | -44.61 | 60 | Off |
| 8 May 2026 | 140.3 EUR | 5.9% | 182.3 EUR | 196.6 EUR | -0.58 | -43.67 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.